ASCO GI 2026: Key Data & Expert Panel Discussion | Dr. Shruti Gohel & Dr. Amol Akhade

OncoWisdom presents an educational review of selected key clinical data from ASCO GI 2026, followed by an expert panel discussion on interpreting the latest evidence in gastrointestinal oncology. *SESSION 1: What's New in Data at ASCO GI 2026* Speaker: Dr. Shruti Gohel A focused review of five important studies: HERIZON-GEA-01 ILLUSTRO KEYNOTE-937 BREAKWATER COMMIT *SESSION 2: How to Make Sense of Data from ASCO GI 2026* Moderator: Dr. Amol Akhade Panelists featured in the recording: Dr. Aparna Parikh Dr. Nina Sanford Dr. Bhawna Sirohi Dr. Anant Ramaswamy The discussion covers emerging evidence in gastric and gastroesophageal cancer, CLDN18.2-targeted treatment, esophageal cancer organ preservation, hepatocellular carcinoma, colorectal cancer, pancreatic cancer and rectal cancer. *VIDEO CHAPTERS* 00:00 Introduction 00:19 What's New at ASCO GI 2026 – Dr. Shruti Gohel 01:50 ILLUSTRO – CLDN18.2-targeted therapy 04:08 KEYNOTE-937 – Adjuvant therapy in HCC 05:10 BREAKWATER – BRAF V600E colorectal cancer 06:35 COMMIT – dMMR colorectal cancer 07:53 Expert Panel Discussion Begins 09:21 HERIZON-GEA-01 – Zanidatamab 18:09 CLDN18.2-targeted treatment 20:30 Perioperative gastric cancer therapy 21:50 Esophageal cancer organ preservation 31:31 Adjuvant therapy in HCC 34:46 Local therapies in HCC 41:37 Treatment considerations in Child-Pugh B HCC 44:03 BRAF V600E metastatic colorectal cancer 47:01 COMMIT and MSI-H colorectal cancer 52:10 Pancreatic cancer 54:26 Rectal cancer – TNT and watch-and-wait 1:00:37 Closing remarks Subscribe to *OncoWisdom* for expert oncology discussions, conference updates and evidence-based educational content. This webinar is intended for medical education and professional discussion. #ASCOGI2026 #GIOncology #OncoWisdom #MedicalOncology #CancerResearch